深川怜史

フカガワサトシ | Fukagawa Satoshi

所属機関・部署：
職名：講師
論文 (7件)：

漆山大知, 深川怜史, 平川豊文, 吉川賢一, 井槌大介, 宮田康平, 倉員正光, 四元房典, 廣松賢治, 太田栄治, et al. MiR-4535 and MiR-1915-5p in Amniotic Fluid as Predictive Biomarkers for Chorioamnionitis. Future Science OA. 2021
宮本新吾, 井槌大介, 深川怜史, 四元房典, 吉川賢一, 清島千尋, 南星旭, 宮田康平, 伊東智宏, 倉員正光, et al. Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer. Anticancer Res. 2018. 38. 7. 4347-4351
Kohei Miyata, Fusanori Yotsumoto, Satoshi Fukagawa, Chihiro Kiyoshima, Nam Sung Ouk, Daichi Urushiyama, Tomohiro Ito, Takahiro Katsuda, Masamitsu Kurakazu, Ryota Araki, et al. Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer. ANTICANCER RESEARCH. 2017. 37. 7. 3955-3960
Satoshi Fukagawa, Fusanori Yotsumoto, Takashi Odawara, Sadao Manabe, Toyokazu Ishikawa, Shin'Ichiro Yasunaga, Shingo Miyamoto. Antitumour Effects of Intravenous Administration of BK-UM, a Novel Inhibitor of HB-EGF, in Ovarian Cancer Therapy. ANTICANCER RESEARCH. 2017. 37. 7. 3891-3896
Fusanori Yotsumoto, Satoshi Fukagawa, Kohei Miyata, Sung Ouk Nam, Takahiro Katsuda, Daisuke Miyahara, Takashi Odawara, Sadao Manabe, Toyokazu Ishikawa, Shin'ichiro Yasunaga, et al. HB-EGF Is a Promising Therapeutic Target for Lung Cancer with Secondary Mutation of EGFR(T790M). ANTICANCER RESEARCH. 2017. 37. 7. 3825-3831

学位 (1件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

深川 怜史